Cutler Group’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-9
Closed -$1K 5840
2020
Q3
$1K Sell
9
-291
-97% -$31.2K ﹤0.01% 4565
2020
Q2
$30K Sell
300
-1,100
-79% -$118K ﹤0.01% 2109
2020
Q1
$151K Buy
1,400
+1,100
+367% +$126K 0.01% 1120
2019
Q4
$34K Buy
+300
New +$34.7K ﹤0.01% 1903
2019
Q1
Sell
-1,356
Closed -$111K 5175
2018
Q4
$102K Sell
1,356
-300
-18% -$22.1K 0.01% 1022
2018
Q3
$132K Buy
1,656
+1,256
+314% +$117K 0.01% 1049
2018
Q2
$39K Buy
+400
New +$34.6K ﹤0.01% 1774
2017
Q4
Sell
-200
Closed -$18K 6658
2017
Q3
$18K Hold
200
﹤0.01% 3256
2017
Q2
$22K Sell
200
-1,744
-90% -$195K ﹤0.01% 3352
2017
Q1
$194K Sell
1,944
-68,902
-97% -$7.36M 0.01% 1222
2016
Q4
$7.62M Buy
70,846
+11,987
+20% +$1.4M 0.27% 49
2016
Q3
$7.33M Sell
58,859
-2,877
-5% -$340K 0.33% 42
2016
Q2
$6.56M Buy
61,736
+52,798
+591% +$6.13M 0.33% 38
2016
Q1
$1.02M Buy
8,938
+1,836
+26% +$215K 0.07% 254
2015
Q4
$1.01M Buy
+7,102
New +$820K 0.06% 334

Other funds holding CBPO

Cutler Group's CBPO Position: Q4 2020 in Review

Cutler Group sold out of China Biologic Products Holdings, Inc. (CBPO) in Q4 2020, closing a stake of 9 shares — an estimated $1K sold.

Cutler Group first reported a position in CBPO in Q4 2015 and held it in 15 quarters. The position peaked at $7.62M in Q4 2016. 89 funds tracked by Wall St. Rank hold CBPO as of Q4 2020.

  • Cutler Group reported no remaining China Biologic Products Holdings, Inc. position as of Q4 2020 after selling out during the quarter.
  • Cutler Group sold 9 China Biologic Products Holdings, Inc. shares in Q4 2020, an estimated $1K.
  • Cutler Group first reported a position in China Biologic Products Holdings, Inc. in Q4 2015 and held it in 15 quarters.
  • Cutler Group's China Biologic Products Holdings, Inc. position peaked at $7.62M in Q4 2016.
  • 89 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q4 2020.

Based on Cutler Group's 13F filing for Q4 2020, filed 21 Jan 2021.